Jeena Sikho LifecareNSE:JSLL +3.81%91 3-Year ROIIC % is 60.31 as of Mar. 2026, which is 45% above its 10-year median of 41.58. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.54 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 617 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 85.41% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Jeena Sikho Lifecare's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 60.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Jeena Sikho Lifecare's 3-Year ROIIC % or its related term are showing as below:
NSE:JSLL's 3-Year ROIIC % is ranked better than 85.41% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.01
vs NSE:JSLL: 60.31
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Jeena Sikho Lifecare 3-Year ROIIC % Related Terms
Jeena Sikho Lifecare 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Jeena Sikho Lifecare (NSE:JSLL) has a 3-Year ROIIC % of 60.31 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Jeena Sikho Lifecare and its competitors. This is 45% above median its historical median of 41.58. Over the past decade, Jeena Sikho Lifecare's 3-Year ROIIC % has ranged from 18.92 to 60.31. According to the industry distribution chart, Jeena Sikho Lifecare ranks #90 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 14.6%.
Is Jeena Sikho Lifecare's 3-Year ROIIC % too high?
Jeena Sikho Lifecare's current 3-Year ROIIC % of 60.31 is 45% above median its 10-year median of 41.58. Over the past 10 years, this metric has ranged from a low of 18.92 to a high of 60.31. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.01. Jeena Sikho Lifecare's value of 60.31 is 1903.7% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #90 out of 617 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #90 out of 617 companies for 3-Year ROIIC %. This places Jeena Sikho Lifecare in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.01. Jeena Sikho Lifecare's value of 60.31 is 1903.7% above this benchmark. Historically, Jeena Sikho Lifecare's own 3-Year ROIIC % has ranged from 18.92 to 60.31 over the past decade. While the company's 10-year median is 41.58 vs. the industry median of 3.01, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.01, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current 3-Year ROIIC % of 60.31 is 1903.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current 3-Year ROIIC % is 60.31, which is 45% above median its own 10-year median of 41.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current 3-Year ROIIC % is 60.31, which is 45% above median its 10-year median of 41.58 and 1903.7% above the Healthcare Providers & Services industry median of 3.01. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current 3-Year ROIIC % is 60.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
3-Year ROIIC %: 60.31 (45% above median its 10-year median of 41.58)
GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
Industry Position: 1903.7% above the Healthcare Providers & Services median (#90 of 617)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
